141 related articles for article (PubMed ID: 14747423)
1. Questioning a class effect: does ACE inhibitor tissue penetration influence the degree of fibrinolytic balance alteration following an acute myocardial infarction?
Tsikouris JP; Suarez JA; Meyerrose GE; Ziska M; Fike D; Smith J
J Clin Pharmacol; 2004 Feb; 44(2):150-7. PubMed ID: 14747423
[TBL] [Abstract][Full Text] [Related]
2. Exploring the effects of ACE inhibitor tissue penetration on vascular inflammation following acute myocardial infarction.
Tsikouris JP; Suarez JA; Simoni JS; Ziska M; Meyerrose GE
Coron Artery Dis; 2004 Jun; 15(4):211-7. PubMed ID: 15187573
[TBL] [Abstract][Full Text] [Related]
3. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition alters the fibrinolytic response to cardiopulmonary bypass.
Pretorius M; Murphey LJ; McFarlane JA; Vaughan DE; Brown NJ
Circulation; 2003 Dec; 108(25):3079-83. PubMed ID: 14656921
[TBL] [Abstract][Full Text] [Related]
5. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
6. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
7. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system.
Usalan C; Buyukhatipoglu H
Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.
Yamada S; Yamada R; Ishii A; Ashikawa K; Kawamitsu H; Fujita K
J Cardiol; 1996 Apr; 27(4):171-8. PubMed ID: 8642503
[TBL] [Abstract][Full Text] [Related]
9. Comparison of effects of quinapril versus enalapril on vasoactive substances following acute myocardial infarction.
Tsikouris JP; Simoni J; Suarez JA; Sutthiwan P; Ziska M; Meyerrose GE
Am J Cardiol; 2004 Sep; 94(5):641-3, A9. PubMed ID: 15342298
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
11. Short-term effects of angiotensin receptor blockers on blood pressure control, and plasma inflammatory and fibrinolytic parameters in patients taking angiotensin-converting enzyme inhibitors.
Agirbasli M; Cincin A; Baykan OA
J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):22-6. PubMed ID: 18404606
[TBL] [Abstract][Full Text] [Related]
12. [Changes in t-PA, PAI-1 gene expression of coronary arteries with preconditioning in acute myocardial infarction rat].
Zhu G; Wu W; Duan Y; Zhang Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Oct; 19(5):319-24. PubMed ID: 10453514
[TBL] [Abstract][Full Text] [Related]
13. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
14. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
[TBL] [Abstract][Full Text] [Related]
15. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
16. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction.
Pedersen OD; Gram J; Jeunemaitre X; Billaud E; Jespersen J
Coron Artery Dis; 1997 May; 8(5):283-91. PubMed ID: 9285181
[TBL] [Abstract][Full Text] [Related]
17. Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin.
Brown NJ; Nadeau JH; Vaughan DE
Thromb Haemost; 1997 Mar; 77(3):522-5. PubMed ID: 9066005
[TBL] [Abstract][Full Text] [Related]
18. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Brown NJ; Agirbasli M; Vaughan DE
Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Goodfield NE; Newby DE; Ludlam CA; Flapan AD
Circulation; 1999 Jun; 99(23):2983-5. PubMed ID: 10368114
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the fibrinolytic system in myocardial infarction].
Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
